Vertaling van "cooperate with other departments " (Nederlands → Frans) :

Efficient cooperation between the departments within a pillar and with relevant departments in the other pillars must be ensured.
Efficient cooperation between the departments within a pillar and with relevant departments in the other pillars must be ensured.

In terms of actions, there were fewer withdrawals on the Belgian market (20% instead of 33%) and there was more cooperation with other departments (in 11% of cases instead of 4%)
In terms of actions, there were fewer withdrawals on the Belgian market (20% instead of 33%) and there was more cooperation with other departments (in 11% of cases instead of 4%)

It is therefore important to cooperate with other departments or bodies in order to tackle problems jointly or simply in order to pass the information on to the competent parties.
It is therefore important to cooperate with other departments or bodies in order to tackle problems jointly or simply in order to pass the information on to the competent parties.

Enhancing the organisation’s image and improving online communication In 2007 an intranet was launched in cooperation with the Communication & Scientific Support service and there are plans to develop a brandnew website with the BUM department that will group existing sites and optimise internal and external communication.
Enhancing the organisation’s image and improving online communication In 2007 an intranet was launched in cooperation with the Communication & Scientific Support service and there are plans to develop a brandnew website with the BUM department that will group existing sites and optimise internal and external communication.

Novartis is also cooperating with an inquiry by the EDPA regarding similar allegations of potential off-label marketing and promotion and payments to healthcare providers in connection with five other products: Diovan, Exforge, Sandostatin, Tekturna and Zelnorm.
Novartis coopère également avec l’EPDA dans le cadre d’une enquête concernant des accusations similaires en relation avec cinq autres produits: Diovan, Exforge, Sandostatine, Tekturna et Zelnorm.

NPC is also cooperating with an investigation by the EDPA regarding potential off-label marketing and promotion as well as payments made to healthcare providers in connection with five other products, i.e.
NPC coopère également à une enquête de l’EDPA sur des accusations de commercialisation et de promotion ainsi que de paiements à des prestataires de soins de santé portant sur des indications pour lesquelles cinq autres produits n’ont pas été autorisés. Il s’agit de Diovan, Exforge, Sandostatine, Tekturna et Zelnorm.

NPC has also been cooperating with an investigation by the EDPA regarding potential off-label marketing and promotion as well as payments made to healthcare providers in connection with five other products, i.e. Diovan, Exforge, Sandostatin, Tekturna and Zelnorm (Five Products).
NPC a également coopéré à une enquête menée par l’EDPA au sujet d’accusations de promotion pour des indications pour lesquelles des produits n’ont pas été autorisés, et de paiements à des prestataires de soins de santé en lien avec cinq autres produits: Diovan, Exforge, Sandostatine, Tekturna et Zelnorm.

NPC is also cooperating with an investigation by the EDPA regarding potential off-label marketing and promotion as well as payments made to healthcare providers in connection with five other products: Diovan, Exforge, Sandostatin, Tekturna and Zelnorm.
NPC coopère également à une enquête menée par l’EDPA au sujet d’accusations de promotion pour des indications pour lesquelles des produits n’ont pas été autorisés, et de paiements à des prestataires de soins de santé en lien avec cinq autres produits: Diovan, Exforge, Sandostatine, Tekturna et Zelnorm.

The R&D (research and development) department of the FAMHP is responsible for the evaluation and approval of clinical research activities, ranging from the first “use” (concept) to extensive trials with medicines that are developed and carried out by university and other research centres and by the pharmaceutical industry.
The R&D (research and development) department of the FAMHP is responsible for the evaluation and approval of clinical research activities, ranging from the first “use” (concept) to extensive trials with medicines that are developed and carried out by university and other research centres and by the pharmaceutical industry.